tiprankstipranks
Trending News
More News >
Lexston Life Sciences Corp. (TSE:LEXT)
:LEXT
Canadian Market

Lexston Life Sciences Corp. (LEXT) Income Statement

Compare
5 Followers

Lexston Life Sciences Corp. Income Statement

Last quarter (Q3 2024), Lexston Life Sciences Corp.'s total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Lexston Life Sciences Corp.'s net income was C$-270.54K. See Lexston Life Sciences Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
C$ 0.00C$ 0.00C$ 361.01KC$ 149.11KC$ 0.00
Gross Profit
C$ -26.39KC$ -29.80KC$ 241.49KC$ 60.10KC$ 0.00
Operating Expenses
C$ 674.72KC$ 871.53KC$ 2.11MC$ 551.19KC$ 6.48K
Depreciation and Amortization
C$ 26.39KC$ 29.80KC$ 31.98KC$ 11.27KC$ 171.86K
EBITDA
C$ -648.32KC$ -841.73KC$ -1.89MC$ -479.82KC$ -6.48K
Operating Income
C$ -674.72KC$ -871.53KC$ -1.86MC$ -106.04KC$ -6.48K
Other Income/Expenses
C$ -59.56KC$ -94.54KC$ -320.59KC$ -385.04KC$ -3.00
Pretax Income
C$ -734.28KC$ -966.07KC$ -2.32MC$ -876.13KC$ -6.48K
Net Income
C$ -867.71KC$ -1.11MC$ -2.32MC$ -876.13KC$ -6.48K
Per Share Metrics
Basic EPS
C$ -0.23C$ -0.34C$ -2.10C$ -0.88C$ -0.01
Diluted EPS
C$ -0.27C$ -0.39C$ -2.10C$ -0.88C$ -0.01
Weighted Average Shares Outstanding
3.77M 3.28M---
Weighted Average Shares Outstanding (Diluted)
3.19M----
Currency in CAD

Lexston Life Sciences Corp. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis